Evidence map›Paper›PMID 40062407›Full record

ArticleStroke2025

Associations Between Stroke Type, Ischemic Stroke Subtypes, and Poststroke Cognitive Trajectories.

Deborah A Levine, Rachael T Whitney, Wen Ye, Emily M Briceño, Alden L Gross, Bruno J Giordani, Jeremy B Sussman, Ronald M Lazar, Virginia J Howard, Hugo J Aparicio and 12 more

Abstract read
In one paragraph

Article in Stroke, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Deborah A LevineDepartments of Internal Medicine (D.A.L., R.T.W., J.B.S., A.S.K., R.A.H.), University of Michigan, Ann Arbor.ORCID 0000-0002-6864-8001
Rachael T WhitneyDepartments of Internal Medicine (D.A.L., R.T.W., J.B.S., A.S.K., R.A.H.), University of Michigan, Ann Arbor.
Wen YeBiostatistics (W.Y.), University of Michigan, Ann Arbor.ORCID 0000-0001-5802-189X
Emily M BriceñoPhysical Medicine and Rehabilitation (E.M.B.), University of Michigan, Ann Arbor.ORCID 0000-0002-9360-8917
Alden L GrossDepartment of Epidemiology, Johns Hopkins University, Baltimore, MD (A.L.G., S.K.).ORCID 0000-0002-4678-0562
Bruno J GiordaniPsychiatry (B.J.G.), University of Michigan, Ann Arbor.ORCID 0000-0001-5921-3455
Jeremy B SussmanDepartments of Internal Medicine (D.A.L., R.T.W., J.B.S., A.S.K., R.A.H.), University of Michigan, Ann Arbor.ORCID 0000-0002-2158-3618
Ronald M LazarDepartments of Neurology (R.M.L.), University of Alabama at Birmingham.ORCID 0000-0002-7388-042X
Virginia J HowardEpidemiology (V.J.H.), University of Alabama at Birmingham.ORCID 0000-0003-4912-9975
Hugo J AparicioDepartments of Neurology (H.J.A., A.S.B., J.R.R.), Boston University, MA.ORCID 0000-0001-8584-1455
Alexa S BeiserDepartments of Neurology (H.J.A., A.S.B., J.R.R.), Boston University, MA.ORCID 0000-0001-8551-7778
Mitchell S V ElkindDepartment of Neurology, Columbia University, New York, NY (M.S.V.E.).ORCID 0000-0003-2562-1156
Rebecca F GottesmanStroke Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD (R.F.G.).ORCID 0000-0002-9504-1256
Silvia KotonDepartment of Epidemiology, Johns Hopkins University, Baltimore, MD (A.L.G., S.K.).ORCID 0000-0002-9327-7505
Sarah T PendleburyNuffield Department of Clinical Neurosciences, University of Oxford, United Kingdom; National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Departments of Medicine and Geratology, Oxford University Hospitals National Health Service (NHS) Foundation Trust, United Kingdom (S.T.P.).ORCID 0000-0003-3603-8388
Adam S KolliparaDepartments of Internal Medicine (D.A.L., R.T.W., J.B.S., A.S.K., R.A.H.), University of Michigan, Ann Arbor.
Mellanie V SpringerNeurology (D.A.L., M.V.S.), University of Michigan, Ann Arbor.ORCID 0000-0002-6281-0143
Sudha SeshadriDepartment of Neurology, University of Texas San Antonio (S.S.).ORCID 0000-0001-6135-2622
Jose R RomeroDepartments of Neurology (H.J.A., A.S.B., J.R.R.), Boston University, MA.ORCID 0000-0002-1101-2950
Annette L FitzpatrickDepartments of Epidemiology (A.L.F., W.T.L.), University of Washington, Seattle.
W T LongstrethDepartments of Epidemiology (A.L.F., W.T.L.), University of Washington, Seattle.
Rodney A HaywardDepartments of Internal Medicine (D.A.L., R.T.W., J.B.S., A.S.K., R.A.H.), University of Michigan, Ann Arbor.

Funding

The Effect of Vascular Risk Factors on Risk of Alzheimer's Disease and Related Dementias after Stroke (STROKE COG)RF1AG068410 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LEVINE, DEBORAH ALLISON · 2020 to 2020
$3.1M
Infrastructure for mentored access to CHS data and specimensR01HL172803 · NHLBI · UNIVERSITY OF WASHINGTON · PI James S Floyd, Michelle Christina Odden · 2025 to 2026
$2.7M
Measurement of cognition and functional decline in Latinx older adults for detection of Alzheimer’s Disease and Related Dementias: A mixed-methods approachK23AG080035 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Emily Marie Briceno · 2023 to 2026
$767k
NHLBI NIH HHS R01 HL172803NIA NIH HHS K23 AG080035NIA NIH HHS RF1 AG068410
6 · The paper itself

Abstract

backgroundIt is unclear how poststroke cognitive trajectories differ by stroke type and ischemic stroke subtype. We studied associations between stroke types (ischemic and hemorrhagic), ischemic stroke subtypes (cardioembolic, large artery atherosclerotic, lacunar/small vessel, and cryptogenic/other determined causes), and poststroke cognitive decline.

methodsWe pooled participants from 4 US cohort studies (1971-2019). Outcomes were change in global cognition (primary) and changes in executive function and memory (secondary). Outcomes were standardized as T scores (mean [SD], 50 [10]); a 1-point difference represents a 0.1 SD difference in cognition. The median follow-up for the primary outcome was 6.0 (interquartile range, 3.2-9.2) years. Linear mixed-effects models estimated changes in cognition after stroke.

resultsWe identified 1143 dementia-free individuals with acute stroke during follow-up: 1061 (92.8%) ischemic, 82 (7.2%) hemorrhagic, 49.9% female, and 30.8% Black. The median age at stroke was 74.1 (interquartile range, 68.6-79.3) years. On average, ischemic stroke survivors showed declines in global cognition (-0.35 [95% CI, -0.43 to -0.27] points/y;

conclusionsStroke survivors had cognitive decline in multiple domains. Declines did not differ by stroke type or ischemic stroke subtype.

Indexed as

Brain IschemiaCognitionCognitive DysfunctionIschemic StrokeAgedAged, 80 and overCohort StudiesExecutive FunctionFemaleHumansMaleMemoryMiddle Agedblood pressurecholesterolcognitionglucosestroke

Identifiers

PMID40062407
PMCPMC12101623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.